Damien Luque-Paz

23PUBLICATIONS
67CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursTumour immunologyPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 04, 2026
Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis.

|Dec 23, 2025
Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Alexandre Guy, Olivier Mansier, Matisse Decilap

|Nov 14, 2025
Pleural Infiltration Revealing Post-Essential Thrombocythemia Acute Myeloid Leukaemia.

Clémentine Muron, Damien Luque Paz, Marie-Christine Copin

|Sep 12, 2025
Association Between Molecular Profile and Outcome After Intensive Chemotherapy in Patients > 60 Years With Secondary and/or Adverse Cytogenetics Acute Myeloid Leukemia-A FILO Study.

Corentin Orvain, Anne Bouvier, Audrey Bidet

|Sep 08, 2025
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study.

Corentin Orvain, Suzanne Tavitian, Clémence Mediavilla

|Jun 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patients.

Olivier Mansier, Eric Lippert, Lina Benajiba

Pageof 4

Frequent Collaborators

8 joint publications

Eric Lippert

7 joint publications

Corentin Orvain

7 joint publications

Jean-Christophe Ianotto

6 joint publications

Jérémie Riou